667, L.P., Director, 10% Owner at IGM Biosciences, Inc. (IGMS), bought 2,826,087 shares at $23.00 ($65.0M) on 2022-04-01, disclosed to the SEC on 2022-04-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.00 | 233,590 | $5.4M | 8.3% |
| 2 | $23.00 | 2,592,497 | $59.6M | 91.7% |
| Total | $23.00 avg | 2,826,087 | $65.0M | 100% |
| Filing → |
| MDGL | BUY | 2023-12-14 | $14.7M | — | Filing → |
| ACAD | BUY | 2023-05-24 | $45.4M | — | Filing → |
| TCRX | BUY | 2022-05-12 | $4.8M | — | Filing → |